STOCK TITAN

BullFrog AI Files Quarterly Report on Form 10-Q

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
AI
Rhea-AI Summary
BullFrog AI Holdings has filed its Form 10-Q with the SEC for the quarter ended March 31, 2023. The company received a notice from Nasdaq regarding non-compliance with periodic filing requirements, but is now in compliance.
Positive
  • BullFrog AI is in compliance with Nasdaq Listing Rule 5250(c)(1)
Negative
  • BullFrog AI received a notice of non-compliance from Nasdaq

GAITHERSBURG, Md., May 26, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of precision medicine, today announced it filed its Form 10-Q with the Securities and Exchange Commission (“SEC”) for the quarter ended March 31, 2023.

BullFrog AI received notice from Nasdaq on May 23, 2023, notifying the Company that it was not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2023 was not filed with the Securities and Exchange Commission by the required due date. The Company is now in compliance with Nasdaq Listing Rule 5250(c)(1).

About BullFrog AI

BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may seek to receive the therapies they need.

For more information visit BullFrogAI at

Website: www.bullfrogai.com

LinkedIn: https://www.linkedin.com/company/bullfrogai/

Safe Harbor Statement

This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Contact:

Dave Gentry
RedChip Companies, Inc.
BFRG@redchip.com
800-733-2447

SOURCE: BullFrog AI Holdings, Inc.


FAQ

What did BullFrog AI announce?

BullFrog AI announced the filing of its Form 10-Q with the SEC for the quarter ended March 31, 2023.

What is the notice from Nasdaq about?

Nasdaq notified BullFrog AI about non-compliance with periodic filing requirements.

Is BullFrog AI now in compliance?

Yes, BullFrog AI is now in compliance with Nasdaq Listing Rule 5250(c)(1).

Bullfrog AI Holdings, Inc.

NASDAQ:BFRG

BFRG Rankings

BFRG Latest News

BFRG Stock Data

19.95M
8.71M
29.2%
3.48%
3.28%
Health Information Services
Pharmaceutical Preparations
Link
United States of America
GAITHERSBURG